Member Info for Newuncle

Ok 13 trades

Fwiw I can only see one sizeable 1.5m trade that could be a sell rather than a buy? The rest mostly look pretty clear cut

Date Time Trade Prc Volume Buy/Sell Bid Ask Value

09-Oct-24 15:28:17 0.177 1,000,000 Buy* 0.16 0.18 1,770 O

09-Oct-24 15:05:12 0.175 419,593 Buy* 0.16 0.18 734.29 O

09-Oct-24 14:55:02 0.177 561,581 Buy* 0.16 0.18 994.00 O

09-Oct-24 14:10:28 0.171 799,975 Buy* 0.16 0.18 1,368 O - SELL

09-Oct-24 14:00:02 0.18 294,118 Buy* 0.16 0.18 529.41 UT - Uncrossing Trade

09-Oct-24 13:45:55 0.177 2,000,000 Buy* 0.16 0.18 3,540 O

09-Oct-24 12:40:54 0.166 37,101 Sell* 0.16 0.18 61.59 O SELL

09-Oct-24 11:39:50 0.177 606,666 Buy* 0.16 0.18 1,074 O

09-Oct-24 11:38:28 0.18 14,085 Buy* 0.16 0.18 25.35 O

09-Oct-24 11:37:00 0.175 1,115,066 Buy* 0.16 0.18 1,951 O

09-Oct-24 11:35:34 0.1655 10,000 Sell* 0.16 0.18 16.55 O SELL

09-Oct-24 09:45:20 0.1701 1,500,000 Buy* 0.16 0.18 2,552 O - BUY or SELL?

09-Oct-24 08:08:38 0.17 588 Sell* 0.17 0.18 1.00 O SELL

With only 12 trades showing can someone please confirm what the BUY and SELL numbers were then?

8M Buys v 50k Sold according to ADVFN.....

No one can tell me this market aint fixed in favour of a powerful player out there....assume its someone like IG or some other spread bet house...ABSOLUTE JOKE and there sweet FA we can do about it

Financial Summary

Summary

The financial performance of the Group for the six months ended 31 March 2024 and its position at that date reflected continued investment in activities to grow adoption and sales of OBD's two on-market tests, alongside further development of its pipeline assets and completion of internal, commercial and grant- and award-funded R&D work.

The raising of £9.9m (before fees) in equity funding post-period end, from new and existing investors, was welcome. As previously noted, the Board aims both to develop test sales sufficient to materially impact the business's ongoing cash burn and to seek to monetize one or more of its assets to provide additional working capital, ideally without recourse to further dilutive equity issues. The Board is encouraged by the recent progress and current prospects of the business as set out in the Chief Executive Officer's report and also acknowledges that success in achieving the aims noted above, and the likely timing of doing so, is uncertain. Management is closely monitoring the Group's expected cashflows and, with the Board, is engaged in a review of costs, to optimally balance preservation of the Group's cash resources and the ongoing development of its business.

At the date of this report, a number of factors make it difficult to predict anticipated product and other commercial revenue and associated cash receipts, or income from any partnership or outlicensing agreement that may provide additional funds. Accordingly, as explained in more detail in Note 2 to the interim financial statements, the Board has concluded (as it did in the annual reports for the years ended 30 September 2022 and 30 September 2023) that there continues to be a material uncertainty which may cast significant doubt on the Group's ability to continue as a going concern.

We plan to update shareholders on progress towards the Group's aims over the remainder of the year, including provision of order volumes for PSE and CiRT for the financial year, shortly after 30 September 2024.

Paul Stockdale

Chief Financial Officer

Tiger,

Why don't you try first?

The focus for PSE is growing sales, and we are allocating extra resource from within our existing team to help do this. We enter the rest of the year with a growing list of agreements in place, providing men with access to the test through concierge medicine clinics as well as through insurance reimbursement. There is huge opportunity to continue to grow sales, focusing initially on large, cash-pay accounts. In the UK, the test is now more accessible through our recently announced partnership with Goodbody, as well as through the growing number of clinics and hospital groups who are choosing to use the test for their private patients.

We will judiciously employ the resources entrusted to us by investors as we strive to hit these targets. We rely on a very experienced but newly established team, patiently pursuing the actions that we know will deliver results, particularly in the US market. It is a team I am proud to lead into the remainder of the year and I look forward to reporting to shareholders on the progress we make together later in the year.

We will have a clearer understanding of the consistency of this trend when we provide an update on test orders to the end of the financial year, shortly after 30 September 2024.

Post what you like, I really do not care

And again Dusty rolls out the "but I'm the victim here" claims......good luck Laura getting any sensible discussion from him here

Enuf said, Dusty plays the man and not the ball and dominates this board, pointless trying to engage with him or anyone else when does nothing but reduce postings to personal attacks.

Because he knows I'm right, that his mindset is not only creating a one-sided narrative on repeat, it's not allowing positive avenues of conversation going forward.

It's a problem for him, that I don't agree that things should be kept with an open mind

Laura,

I'm not going there, not because of you but Dusty.

Hi Laura,

"The fact remains that negative posters have been rightfully angry with BOD..I've stated that last week!!

But people either pick up the phone and ring then or sell"

That's what has been happening for month after month after month.....people had enough and sold it down, the last placing at 9p was the final straw for many I think, then if fell to just 3p......the recent recovery doesn't have anything behind it other than people buying into a bombed SP, unless you know different of course?

Getting busy again on trades...fwiw

Laura,

I have no issue with you or your feedback.

Electric Guitar (ELEG), the digital marketing and advertising company providing first-party data solutions, announced that its subsidiary, 3radical Limited has successfully deployed its Voco platform with Near Field Communication (NFC) technology for the first time. ELEG said it was excited to see 3radical’s continued innovation in bringing real-world experiences into the digital realm. This first use of NFC technology at Grand Designs Live demonstrates the effectiveness of its strategy to combine online and offline data collection methods, ensuring businesses gain real-time, actionable insights to drive better customer engagement.

Comment: After a somewhat shaky start in share price terms, few can argue that ELEG is certainly firing on all cylinders as far as the newsflow is concerned. The real world application of 3radical is particularly pleasing

😂🤡

Same old immature personal attack postings then Dusty....didn't take long, pathetic you are.

Oh Dusty,

How the world has changed for you, few weeks ago at 3p it was resigned to your fate etc etc. Now all is well and us posters who are not in the happy clappy brigade are negaive, pessimistic, disgruntled blah blah blah.

Flip the coin, that makes you a Bull Sh** ramper trying to sell this to others knowing that it is a financial basket case with the one of the worst CEOs and FDs on AIM. Total shareholder destruction in terms of the share price and one placing after another and another.

Guess you are happy now you've started this little war again with your ridiculous postings going all personal.

No doubt your next comment will be the usual accusations of bullying by others and you will never give in etc etc.....

Same Old Same Old

Dusty,

If Burrows has any commercial awareness of the share price then he would be wise not to release any test numbers imo and let the bottom fishers work the shares over.

I Concur V,

The historic accounts would in no way whatsoever reflect the business going forwards.

"It is hardly surprising that the accounts are being withheld . IF they were to release the accounts and the stock was relisted they might well be creating a false market in a Company that has radically changed its structure ."